Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases

被引：24
作者：
Fordy, C [1 ]
Glover, C [1 ]
Davies, MM [1 ]
Allen-Mersh, TG [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, Dept Gastrointestinal Surg, London, England
来源：
BRITISH JOURNAL OF CANCER | 1998年 / 78卷 / 08期
关键词：
colorectal liver metastases; chemotherapy; fluorouracil resistance; hepatic arterial floxuridine;
D O I：
10.1038/bjc.1998.627
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatic arterial floxuridine (HAI) in 35 patients with systemic fluorouracil/folinic acid-resistant colorectal liver metastases achieved a 14% partial response and 26% disease stabilization rate, with a median response duration of 7 months from onset of HAI.
引用
收藏
页码：1058 / 1060
页数：3
相关论文
共 32 条
  • [1] QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES
    ALLENMERSH, TG
    EARLAM, S
    FORDY, C
    ABRAMS, K
    HOUGHTON, J
    [J]. LANCET, 1994, 344 (8932) : 1255 - 1260
  • [2] SIGNIFICANCE OF A FALL IN SERUM CEA CONCENTRATION IN PATIENTS TREATED WITH CYTO-TOXIC CHEMOTHERAPY FOR DISSEMINATED COLORECTAL-CANCER
    ALLENMERSH, TG
    KEMENY, N
    NIEDZWIECKI, D
    SHURGOT, B
    DALY, JM
    [J]. GUT, 1987, 28 (12) : 1625 - 1629
  • [3] THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE
    BERGNER, M
    BOBBITT, RA
    CARTER, WB
    GILSON, BS
    [J]. MEDICAL CARE, 1981, 19 (08) : 787 - 805
  • [4] EFFECT OF ABERRANT HEPATIC ARTERIAL ANATOMY ON TUMOR RESPONSE TO HEPATIC-ARTERY INFUSION OF FLOXURIDINE FOR COLORECTAL LIVER METASTASES
    BURKE, D
    EARLAM, S
    FORDY, C
    ALLENMERSH, TG
    [J]. BRITISH JOURNAL OF SURGERY, 1995, 82 (08) : 1098 - 1100
  • [5] Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre
    Burke, D
    Fordy, C
    Earlam, SA
    AllenMersh, TG
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (08) : 1213 - 1216
  • [6] RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    BUROKER, TR
    OCONNELL, MJ
    WIEAND, HS
    KROOK, JE
    GERSTNER, JB
    MAILLIARD, JA
    SCHAEFER, PL
    LEVITT, R
    KARDINAL, CG
    GESME, DH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 14 - 20
  • [7] MEASURING PSYCHOLOGICAL AND PHYSICAL DISTRESS IN CANCER-PATIENTS - STRUCTURE AND APPLICATION OF THE ROTTERDAM-SYMPTOM-CHECKLIST
    DEHAES, JCJM
    VANKNIPPENBERG, FCE
    NEIJT, JP
    [J]. BRITISH JOURNAL OF CANCER, 1990, 62 (06) : 1034 - 1038
  • [8] MEASUREMENT OF RESPONSE TO TREATMENT IN COLORECTAL LIVER METASTASES
    DWORKIN, MJ
    BURKE, D
    EARLAM, S
    FORDY, C
    ALLENMERSH, TG
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 873 - 876
  • [9] Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases
    Earlam, S
    Glover, C
    Fordy, C
    Burke, D
    AllenMersh, TG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 171 - 175
  • [10] Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients
    Earlam, S
    Glover, C
    Davies, M
    Fordy, C
    AllenMersh, TG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 2022 - 2029
1234